AMAKEM

Amakem is a kinase platform company focusing on ophthalmology and is developing new treatments for serious eye conditions. Amakem's product pipeline is based on its unique â€˜Localized Drug Action' platform which is designed to generate safe and effective novel kinase inhibitors that minimize systemic exposure with the aim of reducing side effects.

#SimilarOrganizations #People #Financial #Website #More

AMAKEM

Industry:

Biotechnology Medical Therapeutics

Founded:

2010-01-01

Address:

Diepenbeek, Limburg, Belgium

Country:

Belgium

Website Url:

http://www.amakem.com

Total Employee:

11+

Status:

Active

Contact:

32-(0)-11-286-982

Email Addresses:

[email protected]

Total Funding:

25.23 M USD

Technology used in webpage:

Viewport Meta IPhone / Mobile Compatible Google Analytics Apple Mobile Web Clips Icon Google Tag Manager Content Delivery Network Google Universal Analytics Font Awesome Global Site Tag Nginx

Similar Organizations

apogenix-logo

Apogenix

Apogenix is a biopharmaceutical company developing novel protein therapeutics for the treatment of cancer and inflammatory diseases.

rhovac-aps-logo

Rhovac ApS

RhoVac is an immuno-oncology company developing a novel therapeutic cancer vaccine that targets metastatic cancer cells.

Current Employees Featured

not_available_image

Dirk Leysen
Dirk Leysen Owner @ Amakem
Owner

Founder

not_available_image

Dirk Leysen

not_available_image

Nadya Kaval

not_available_image

Olivier Defert

Investors List

omnes-capital_image

Official Site Inspections

http://www.amakem.com

Host Informations
Whois Informations

Loading ...